An Open Label Study of the Effects of Eculizumab in CD59 Deficiency

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Mevorach Dror, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01579838
First received: February 23, 2012
Last updated: April 17, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)